Investors

Notice of the unsecured creditors’ meeting as directed by the NCLT to seek approval for the Scheme of Arrangement between Mylan Laboratories Limited, Mylan Healthcare Private Limited and their respective shareholders

Notice of the unsecured creditors’ meeting as directed by the NCLT to seek approval for the Scheme of Arrangement between Mylan Laboratories Limited, Mylan Drugs India Private Limited and their respective shareholders

Notice of 34th Annual General Meeting

Extract of Annual Return for the financial year ended March 31, 2019

Notice of the unsecured creditors meeting as directed by the NCLT to seek approval for the amalgamation of Madaus Pharmaceuticals Private Limited with Mylan Laboratories Limited

Notice of 33rd Annual General Meeting

Notice of Extra ordinary general Meeting-28-June-2017

Notice of Annual General Meeting-16-Dec-2016

Notice of Extra ordinary general meeting-30-Sep-2016

 

Composition of the CSR Committee:

Name	Position
Mr. Rakesh Bamzai	Chairman
Mr. Rajiv Krishan Luthra	Member
Ms. Sarada Kalyani Bhagawati	Member

 

Contact information for investor grievances and grievances for CSR programs:
B. Nagaraj Goud,
Company Secretary and Associate Vice President – Compliance
Mylan Laboratories Limited
Plot No. 564/A/A22, Road No. 92,
Jubilee Hills, Hyderabad. Pin: 500 034, Telangana, India
Email: Nagaraj.bodige@mylan.in
Telephone: +91 40 3086 6088